Published in Ter Arkh on January 01, 1991
CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest (1999) 1.45
A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood (1997) 1.29
Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene (1994) 1.20
Identification of transcriptional activation and repression domains in human CCAAT/enhancer-binding protein epsilon. J Biol Chem (1998) 1.04
C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters. Blood (1999) 0.99
Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP epsilon). Blood (1997) 0.95
Representational difference analysis using myeloid cells from C/EBP epsilon deletional mice. Blood (2000) 0.83
C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia. Leuk Res (1997) 0.82
p53 transactivation through various p53-responsive elements. Mol Carcinog (1996) 0.79
Liposoluble vitamins E and A in human renal cortex and renal cell carcinomas. Nephron (1995) 0.79
DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein epsilon (C/EBPepsilon) gene. Leuk Res (2001) 0.79
[Lesions of the upper segments of the gastrointestinal tract in children with scleroderma]. Revmatologiia (Mosk) (1986) 0.78
[Campylobacter pylori gastroduodenitis in children with juvenile rheumatoid arthritis]. Revmatologiia (Mosk) (1992) 0.77
[Morphological and endoscopic characteristics of chronic gastroduodenitis in children with lesions of the hepatobiliary system and pancreas]. Arkh Patol (1986) 0.76
[Cartilage-protective preparations in the therapy of osteoarthrosis]. Ter Arkh (1992) 0.75
[Various aspects of the functional interpretation of the sonocardiokinetogram]. Kardiologiia (1972) 0.75
[Morphology of psoriatic arthritis]. Arkh Patol (1985) 0.75
[Yersiniosis as a therapeutic problem]. Ter Arkh (2000) 0.75
[Reactive arthritis. The problems of theory and practice]. Ter Arkh (1991) 0.75
[On some mechanisms of the compensation of heart action in patients who have sustained a myocardial infarct]. Kardiologiia (1968) 0.75
[HLA-antigens and some pathogenetic aspects of reactive arthritis]. Ter Arkh (1998) 0.75
[Diagnostic criteria of osteoarthrosis deformans and the potentials for their practical application]. Revmatologiia (Mosk) (1984) 0.75
[The microbiocenosis of the intestines and its influence on the course of postenterocolitic reactive arthritis]. Revmatologiia (Mosk) (1990) 0.75
[Clinical importance of determining circulating immune complexes in patients with gouty arthritis]. Revmatologiia (Mosk) (1989) 0.75
[Yersinia enterocolitica and rheumatic diseases (a review of the literature)]. Vopr Revm (1979) 0.75
[Status of the heart atrium in patients with hypertension]. Ter Arkh (1969) 0.75
[Intra-articular administration of glucocorticoids in rheumatoid arthritis from the doctor and patient's viewpoint]. Ter Arkh (1989) 0.75
[Symptomatology of spinal lesions in Reiter's disease and psoriatic arthritis]. Ter Arkh (1980) 0.75
[Late results of the D-penicillamine treatment of rheumatoid arthritis]. Vopr Revm (1982) 0.75
[Diagnosis of pathology of the atrium by the bloodless instrumental method]. Kardiologiia (1971) 0.75
[Sensitization of Yersinia arthropathy patients to HLA-B27 antigen]. Revmatologiia (Mosk) (1985) 0.75
[Differential diagnosis of seronegative arthritis]. Ter Arkh (1986) 0.75
[THe treatment of patients with chronic disease: the viewpoint of the physician and of the patient (exemplified by rheumatoid arthritis)]. Ter Arkh (1993) 0.75
[The development and testing of diagnostic criteria in psoriatic arthritis]. Ter Arkh (1989) 0.75
[Vladimir Nikitich Vinogradov (100th anniversary of his birth)]. Kardiologiia (1982) 0.75
[Ankylosing spondylarthritis beginning in childhood]. Ter Arkh (1991) 0.75
[Arthrography of shoulder joints in patients with humeroscapular periarthritis]. Ter Arkh (1982) 0.75
[Leukocyte function in reactive arthritis]. Revmatologiia (Mosk) (1991) 0.75
[Development of studies on problem of infectious arthritis at the Institute of RHeumatology, Russian Academy of Medical Sciences in 1970 to 1990]. Vestn Ross Akad Med Nauk (1998) 0.75
[Diagnosis of monoarthritis of the knee joint]. Ter Arkh (1979) 0.75
[Clinical diagnosis and activity of the process in several variants of the course of infectious nonspecific polyarthritis]. Vopr Revm (1970) 0.75
[Bechterew's disease and other types of seronegative spondyloarthritis (spondyloarthropathies)--common and distinguishing features]. Revmatologiia (Mosk) (1985) 0.75
[Microcirculatory disorders in patients with psoriatic arthritis]. Ter Arkh (1991) 0.75
[Clinico-morphological aspects of arthritis in Reiter's disease]. Revmatologiia (Mosk) (1986) 0.75
[Yersinia arthropathy: various clinical and diagnostic aspects]. Ter Arkh (1983) 0.75
[Regimen for patients with myocardial infarct]. Ter Arkh (1971) 0.75
[Reactive arthritis: the status of the problem and the outlook]. Revmatologiia (Mosk) (1985) 0.75
[State of nonspecific resistance of the body in patients with reactive arthritis as affected by whole-body UV radiation]. Vopr Kurortol Fizioter Lech Fiz Kult (1988) 0.75
[The state of the gastrointestinal tract in reactive arthritis]. Vestn Akad Med Nauk SSSR (1989) 0.75
[A working classification and nomenclature of rheumatic diseases (pediatric aspects)]. Pediatriia (1989) 0.75
[The comparative value of clinico-instrumental signs for diagnosis of cardiac aneurysm]. Kardiologiia (1972) 0.75
[Controlled (double blind) study of various regimens of levamisole administration in rheumatoid arthritis]. Ter Arkh (1983) 0.75
[Achievements of modern antirheumatism therapy]. Klin Med (Mosk) (1982) 0.75
[Arthritis]. Klin Med (Mosk) (1991) 0.75
[The comparative efficacy of slow-acting (basic) preparations in psoriatic arthritis]. Ter Arkh (1992) 0.75
[Problems of the pathogenesis, diagnosis and differential diagnosis of seronegative spondylarthritis]. Ter Arkh (1986) 0.75
[Experience with the D-penicillamine treatment of rheumatoid arthritis]. Vopr Revm (1978) 0.75
[Microbiocenosis and the status of the intestinal mucosa in alkylosing spondyloarthritis]. Ter Arkh (1990) 0.75
[Etiological role of Halprovia-microorganisms of PLT group in diseases of joints. I. Excretion of Halprovia arthritidis from joints of patients with rheumatoid monosynovitis and Reiter's syndrome]. Vopr Revm (1974) 0.75
[Clinical variants and the morphological picture of the joint syndrome in patients with psoriasis]. Ter Arkh (1983) 0.75
[Rheumatic polymyalgia]. Vopr Revm (1977) 0.75
[Treatment of rheumatoid arthritis with prolonged-action drugs]. Klin Med (Mosk) (1980) 0.75
[Immunoglobulin E in ankylosing spondylarthritis]. Klin Med (Mosk) (1991) 0.75
[Pathogenesis of chronic forms of yersiniosis]. Klin Med (Mosk) (1988) 0.75
[Current state of the arthrosis problem]. Vopr Revm (1970) 0.75
[Activity of lysosomal enzymes in the blood and synovial fluid in joint diseases]. Ter Arkh (1977) 0.75
[Clinical and laboratory characteristics of different forms and variants of the course of rheumatoid arthritis]. Vopr Revm (1977) 0.75
[Possible etiological role of Halprovia (microorganisms of PLT group) in the development of nonspecific inflammatory diseases of the joints]. Ter Arkh (1973) 0.75
[Symptoms of clinico-anatomical variants of humeroscapular periarthritis (periarthrosis)]. Revmatologiia (Mosk) (1983) 0.75
[Working classification and nomenclature of rheumatic diseases]. Revmatologiia (Mosk) (1989) 0.75
[Approach to evaluation of the indicators of Yersinia infections in reactive and rheumatoid arthritis]. Revmatologiia (Mosk) (1991) 0.75
[The clinico-genetic characteristics of combined forms of seronegative spondylarthritis]. Ter Arkh (1997) 0.75
[Functional state of the atria in ischemic heart disease (postinfarct cardiosclerosis)]. Kardiologiia (1973) 0.75
[Significance of electrocardiogram changes in patients with hypertensive disease]. Kardiologiia (1970) 0.75
[The efficacy of bifidum-containing preparations in enterogenous reactive arthritis]. Ter Arkh (1991) 0.75
[Working classification and nomenclature of rheumatic diseases (1985)]. Revmatologiia (Mosk) (1986) 0.75
[Epidemiological criteria for diagnosing infectious nonspecific polyarthritis]. Vopr Revm (1971) 0.75
[Clinical aspects and the course of infectious nonspecific polyarthritis according to data of the Arthrological department of Moscow City Hospital No. 13]. Sov Med (1966) 0.75
[Various aspects of the chronic course of Reiter's disease]. Ter Arkh (1986) 0.75
[Myocarditis in Reiter's disease]. Ter Arkh (1984) 0.75
[Study of sulfopolysaccharides of the synovial fluid in infectious nonspecific polyarthritis to characterize destructive processes in joints]. Vopr Revm (1970) 0.75
[Current studies on etiology of rheumatoid arthritis and related diseases]. Ter Arkh (1977) 0.75
[Clinical symptomatology and various problems of treatment of Reĭter's disease]. Ter Arkh (1978) 0.75
[Determination of Klebsiella pneumoniae antigens in the serum of patients with Bechterew's disease]. Revmatologiia (Mosk) (1987) 0.75
[Scintigraphy with 99mTc-pyrophosphate in patients with scapulohumeral periarthritis]. Ter Arkh (1981) 0.75
[Evaluation of the activity of the inflammatory process in ankylosing spondyloarthritis]. Revmatologiia (Mosk) (1991) 0.75
[Urogenital infection in Reiter's disease, rheumatoid arthritis and Bechterew's disease]. Ter Arkh (1980) 0.75
[Diagnostic criteria of gout for mass examinations]. Revmatologiia (Mosk) (1985) 0.75
[Autoimmune reactions to synovial membrane and articular cartilage in rheumatoid arthritis]. Ter Arkh (1978) 0.75
[Clinical aspects of rheumatic polymyalgia]. Ter Arkh (1976) 0.75